Drug recall · August 7, 2024
Clonazepam Orally Disintegrating Tablets recall
Why: Labeling: Label Error on Declared Strength; Some cartons were incorrectly labeled as 0.125 mg instead of 0.25 mg. The blister strips inside the product carton reflect the correct strength of 0.25 mg.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Clonazepam Orally Disintegrating Tablets, USP (C-IV) 0.125mg, 60 tablets per carton (10 blister cards containing 6 tablets each), Rx Only, Distributed by: Par Pharmaceutical, Chestnut Ridge, NY 10977, NDC# 49884-306-02.
- Lots / codes
Lot 550147301, Exp. 08/31/2026
- Quantity
- 8,139 cartons
- Company
- Endo Pharmaceuticals, Inc., Malvern, PA
- Distribution
- Nationwide in the USA and Puerto Rico
- Initiated
- July 10, 2024 · Voluntary: Firm initiated
- Classified
- July 30, 2024
- Reported
- August 7, 2024
- Ended
- September 16, 2025
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Clonazepam
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.